N/A
N=78
Vestibular Testing: Consistency and Effects Over Time
Dizziness
Bottom Line
View on ClinicalTrials.gov: NCT03182868 ↗Enrolled (actual)
78
Serious AEs
0.0%
Results posted
Sep 2021
Primary outcome: Primary: Vestibular Reaction Times — 240.89; 202.96; 233.09; 228.95 msec
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- PAS Goggle (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Miami
- Primary completion
- Nov 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Vestibular Reaction Times |
240.89; 202.96; 233.09; 228.95; 202.27; 213.07 | — |
| PRIMARY Vestibular Subjective Visual Vertical |
2.08; 2.04; 1.21; 1.52; 1.52; 1.64 | — |
| PRIMARY Vestibular Smooth Pursuit Horizontal |
10006; 10739; 10303; 9986; 10450; 10219 | — |
| PRIMARY Vestibular Percentage of Saccade |
12.83; 16.49; 21.23; 12.72; 14.38; 18.23 | — |
| PRIMARY Vestibular Anti-Saccade |
39.09; 23.75; 34.56; 28.17; 21.88; 24.26 | — |
| PRIMARY Vestibular Gain |
0.74; 0.78; 0.79; 0.72; 0.97; 0.77 | — |
| PRIMARY Vestibular Saccade Horizontal |
0.17; 0.18; 0.18; 0.18; 0.18; 0.18 | — |
| PRIMARY Vestibular Predictive Saccade |
37.04; 36.52; 35.88; 32.66; 27.50; 35.12 | — |
| PRIMARY Motion Sickness as Measured by the MSAQ |
— | — |
Summary
The goal of this study is to test the consistency and repeatability of a portable goggle system for testing optokinetic, ocular, and reaction time. The study examines the day to day consistency, time of day and learning effects as well as any secondary motion sickness.
Eligibility Criteria
Inclusion Criteria
- Age 18 to 65
- Both Females and males
- Staff and students at all levels at the University of Miami or first-degree - relatives/significant others of those individuals.
Exclusion Criteria
- History of vestibular disorder/dysfunction
- Central processing disorder
- Impaired vision without corrective lenses (max 20/60 uncorrected)
- Moderate to severe hearing loss [>55 decibel (dB) Pure Tone Average (PTA), <50% word identification]
Data sourced from ClinicalTrials.gov (NCT03182868). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.